Abstract
The systemic inflammatory response (SIRS) and its associated syndromes [1] represent formidable problems in critical care medicine, afflicting more than 1% of hospital patients. In 40% of cases, circulatory failure or septic shock ensues with an associated mortality of 40–80%, resulting in approximately 250, 000 deaths per annum in the United States alone [2]. Death is usually attributable to the multi-organ dysfunction syndrome (MODS).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874
Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26:2078–2086
Luce JM (1998) Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 26:369–376
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Opal SM, Cohen J (1999) Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 27:1608–1616
Brun-Buisson C, Doyon F, Carlet J (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154:617–624
Sriskandan S, Cohen J (1999) Gram-positive sepsis. Mechanisms and differences from gramnegative sepsis. Infect Dis Clin North Am 13:397–412
Cohen J, Abraham E (1999) Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock. J Infect Dis 180:116–121
Menzies BE, Kourteva I (1998) Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 66:5994–5998
Grimminger F, Rose F, Sibelius U, et al (1997) Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol 159:1909–1916
Pugin J, Ulevitch RJ, Tobias PS (1995) Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD 14. Prog Clin Biol Res 392:369–373
Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD (1995) Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 182:1673–1682
Beutler B (2000) Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20–26
Medzhitov R, Janeway CI Jr. (2000) Review Articles: Advances in Immunology: Innate Immunity. N Engl J Med 343:338–344
Blease K, Chen Y, Hellewell PG, Burke-Gaffney A (1999) Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells. J Immunol 163:6139–6147
Levashina EA, Langley E, Green C, et al (1999) Constitutive activation of toll-mediated antifungal defense in serpin-deficient Drosophila. Science 285:1917–1919
Watari M, Watari H, Nachamkin I, Strauss JF (2000) Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells. J Soc Gynecol Investig 7:190–198
Balk RA, Bone RC (1989) The septic syndrome. Definition and clinical implications. Crit Care Clin 5:1–8
Marks JD, Marks CB, Luce JM, et al (1990) Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141:94–97
Pittet JF, Mackersie RC, Martin TR, Matthay MA (1997) Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155: 1187–1205
Donnelly TJ, Meade P, Jagels M, et al (1994) Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 22:768–776
Anonymous (1999) Proceedings of the 41st Annual Thomas L. Petty Aspen Lung Conference: Acute Lung Injury. Chest 116:1S–127S
Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A (1998) Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med 158:3–11
van Deventer SJH (2000) Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 26:S98–S102
Millar AB, Foley NM, Singer M, Johnson NM, Meager A, Rook GA (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712–714
Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM (1992) High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 145:1016–1022
Miller EJ, Cohen AB, Nagao S, et al (1992) Elevated levels of NAP-l/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146:427–432
Goodman RB, Strieter RM, Martin DP, et al (1996) Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154:602–611
Zapol WM, Snider MT (1977) Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 296:476–480
Snapper JR, Thabes JS, Lefferts PL, Lu W (1998) Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep. Am J Respir Crit Care Med 157:81–88
Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG (1979) Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 120:1039–1052
Archer SL, Weir EK, Reeve HL, Michelakis E (2000) Molecular identification of 02 sensors and O2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol 475:219–240
Liu SF, Crawley DE, Barnes PJ, Evans TW (1991) Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 143:32–37
Singh S, Anning PB, Winlove CP, Evans TW (1999) Permeability of aortuc endothelium to albumin is altered by sepsis and L-NAME. Am J Respir Crit Care Med 159:A613 (Abst)
Nunokawa Y, Ishida N, Tanaka S (1994) Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun 200:802–807
Liu SF, Ye X, Malik AB(1997) In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 159:3976–3983
Kamijo R, Harada H, Matsuyama T, et al (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612–1615
Spink J, Evans T (1997) Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J Biol Chem 272:24417–24425
Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW (1993) Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196:1208–1213
Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW (1996) Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24:1219–1225
MacNaul KL, Hutchinson NI (1993) Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 196:1330–1334
Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL (1999) An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27:913–922
Tsukahara Y, Morisaki T, Horita Y, Torisu M, Tanaka M (1998) Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients. World J Surg 22:771–777
Annane D, Sanquer S, Sebille V, et al (2000) Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 355:1143–1148
Griffiths MJ, Curzen NP, Mitchell JA, Evans TW (1997) In vivo treatment with endotoxin increases rat pulmonary vascular contractility despite NOS induction. Am J Respir Crit Care Med 156:654–658
Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T (1988) A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 6:S188–S191
Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD (1998) Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. J Cardiovasc Pharmacol 31:S348–S350
Michael JR, Markewitz BA (1996) Endothelins and the lung. Am J Respir Crit Care Med 154:555–581
Curzen NP, Jourdan KB, Mitchell JA (1996) Endothelial modification of pulmonary vascular tone. Intensive Care Med 22:596–607
Dupuis J, Stewart DJ, Cernacek P, Gosselin G (1996) Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94:1578–1584
Langleben D, DeMarchie M, Laporta D, Spanier AH, Schlesinger RD, Stewart DJ (1993) Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 148:1646–1650
Curzen NP, Griffiths MJ, Evans TW (1995) Contraction to endothelin-1 in pulmonary arteries from endotoxin-treated rats is modulated by endothelium. Am J Physiol 268: H2260–H2266
Curzen NP, Mitchell JA, Jourdan KB, Griffiths MJ, Evans TW (1996) Endothelin-1-induced contraction of pulmonary arteries from endotoxemic rats is attenuated by the endothelin-A receptor antagonist, BQ123. Crit Care Med 24:2007–2013
Guc MO, Furman BL, Parratt JR (1990) Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 101:913–919
Lundberg JM, Weitzberg E, Rudehill A, Hemsem A, Modin A (1995) The endothelin receptor antagonist bosentan reduces pulmonary hypertension in endotoxin shock. Am J Respir Crit Care Med 151:A317 (abst)
Gardiner SM, Kemp PA, March JE, Bennett T (1995) Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br J Pharmacol 116:1718–1719
Curzen NP, Kaddoura S, Griffiths MJ, Evans TW (1997) Endothelin-1 in rat endotoxemia: mRNA expression and vasoreactivity in pulmonary and systemic circulations. Am J Physiol 272:H2353–H2360
Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S (1995) Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 79:2122–2131
Kirshbom PM, Tsui SS, DiBernardo LR, et al (1995) Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest. Surgery 118:440–444
Ziesche R, Petkov V, Williams J, et al (1996) Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc Natl Acad Sci USA 93:12478–12483
Mitchell JA, Larkin S, Williams TJ (1995) Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 50:1535–1542 50:1535–1542
Petrak RA, Balk RA, Bone RC (1989) Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin 5:303–314
Leeman M, Boeynaems JM, Degaute JP, Vincent JL, Kahn RJ (1985) Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome. Chest 87:726–730
Ahmed T, Wasserman MA, Muccitelli R, Tucker S, Gazeroglu H, Marchette B (1986) Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics: role of lipoxygenase and cyclooxygenase products. Am Rev Respir Dis 134:1149–1157
McCormack DG, Mehta S, Tyml K, Scott JA, Potter R, Rohan M (2000) Pulmonary microvascular changes during sepsis evaluation using intravital microscopy. Microvasc Res 60:131–140
Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068–2101
Thompson RD, Wakelin MW, Larbi KY, et al (2000) Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo. J Immunol 165:426–434
Werr J, Xie X, Hedqvist P, Ruoslahti E, Lindbom L (1998) betal integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. J Exp Med 187:2091–2096
Nieuwenhuijzen GA, Knapen MF, Oyen WJ, Hendriks T, Corstens FH, Goris RJ (1997) Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ dysfunction syndrome. Shock 7:98–104
Michel CC, Curry FE (2000) Microvascular permeability. Physiol Rev 79:703–761
Merkle CJ, Wilson LM, Baldwin AL (1998) Acute blood stasis reduces interstitial uptake of albumin from intestinal microcirculatory networks. Am J Physiol 274:H600–H608
Yuan Y, Granger HJ, Zawieja DC, Chilian WM (1992) Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol 263:H641–H646
Schnitzer JE, Allard J, Oh P (1995) NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. Am J Physiol 268:H48–H55
Michel CC (1996) Transport of macromolecules through microvascular walls. Cardiovasc Res 32:644–653
Grega GJ, Adamski SW, Dobbins DE (1986) Physiological and pharmacological evidence for the regulation of permeability. Fed Proc 45:96–100
Majno G, Shea SM, Leventhal M (1969) Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol 42:647–672
Haupt MT (1989) The use of crystalloidal and colloidal solutions for volume replacement in hypovolemic shock. Crit Rev Clin Lab Sci 27:1–26
Deng X, Wang X, Andersson R (1995) Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol 78:2052–2061
Hunter DN, Lawrence R, Morgan CJ, Evans TW (1990) The use of caesium iodide mini scintillation counters for dual isotope pulmonary capillary permeability studies. Nucl Med Commun 11:879–888
Boughton-Smith NK, Evans SM, Whittle BJ, Moncada S (1993) Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents Actions 38:C125–C126
Arfors KE, Rutili G, Svensjo E (1979) Microvascular transport of macromolecules in normal and inflammatory conditions. Acta Physiol Scand Suppl 463:93–103
Shepro D, Morel NM (1993) Pericyte physiology. Faseb J 7:1031–1038
Bannerman DD, Sathyamoorthy M, Goldblum SE (1998) Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 273:35371–35380
Kurose I, Kubes P, Wolf R, et al (1993) Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73:164–171
Panes J, Perry MA, Anderson DC, et al (1995) Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 269:H1955–H1964
Gautam N, Herwald H, Hedquist P, Lindbom L (2000) Signalling via beta-2 integrins triggers neutrophil-dependent alteration in endothelial barrier function. J Exp Med 191:1829–1839
Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611–H615
Mayhan WG (1994) Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 266:H2369–H2373
Filep JG, Delalandre A, Beauchamp M (1997) Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Circ Res 81:840–847
Arkovitz MS, Wispe JR, Garcia VF, Szabo C (1996) Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 31:1009–1015
Abraham E (2000) Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 22:401–404
Levi M, ten Cate H, Bauer EKA, et al (1994) Inhibition of endotoxin-induced activation of coagulation adn fibrinolysis by pentoxifylline or by a monoldonal anti-tissue factor antibody in a chimpanzee model. J Clin Invest 93:114–120
Drake TA, Cheng J, Chang A, Taylor FB (1993) Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia cole sepsis. Am J Pathol 142:1458–1470
Saadi S, Holzkecht RA, Patte CP, Stern DM, Platt JL (1995) Complement mediated regulation of tissue factor activity in endothelium. J Exp Med 182:1807–1814
Pietra GG, Ruttner JR, Wust W, Glinz W (1981) The lung after trauma and shock-fine structure of the alveolar-capillary barrier in 23 autopsies. J Trauma 21:454–462
Idell S, Gonzalez K, Bradford H, et al (1987) Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis 136:1466–1474
Ware LB, Matthay MA (1996) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Finney, S.J., Wort, S.J., Evans, T.W. (2002). Pulmonary Vascular Dysfunction. In: Evans, T.W., Fink, M.P. (eds) Mechanisms of Organ Dysfunction in Critical Illness. Update in Intensive Care and Emergency Medicine, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56107-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-56107-8_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42692-9
Online ISBN: 978-3-642-56107-8
eBook Packages: Springer Book Archive